FDA panel expected to vote on a third Pfizer COVID-19 shot ahead of White House deadline

FDA panel expected to vote on a third Pfizer COVID-19 shot ahead of White House deadline – CBS News

Watch CBSN Live


A Food and Drug Administration advisory committee is expected to vote on the safety and efficacy of a third dose of the Pfizer-BioNTech vaccine. CBS News’ Natalie Brand reports on the debate over whether vaccinated Americans need booster shots, and CBS News researcher Max Bayer has more on the FDA hearing.

View CBS News In

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.